TECH
Bio-Techne Corp
72.40$
-0.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.2% | -0.3% | +18.8% | +6.6% | +13.0% | +71.6% | -7.6% | -21.8% | +17.5% | -3.8% | +1.6% | |
| – | +14.9% | +40.4% | +7.4% | +21.3% | +5.8% | +6.1% | +15.2% | +6.1% | +4.2% | -1.6% | -11.4% | |
| – | +58.3% | +55.2% | +93.0% | +14.3% | +0.3% | +51.3% | -13.9% | -7.0% | -3.0% | +7.3% | +1.3% | |
| – | +148.0% | +61.2% | -196.1% | – | +108.0% | +116.3% | -150.5% | – | – | – | – | |
| – | – | – | – | -1,563.7% | – | – | -337.6% | – | – | – | -457.9% | |
| – | -15.1% | -10.2% | +37.9% | +21.4% | +103.6% | -14.4% | +1.4% | -14.8% | +64.4% | -50.7% | -7.0% | |
| – | -74.8% | +184.4% | -87.3% | +770.0% | – | -998.7% | -60.2% | +174.3% | -23.6% | -82.7% | -48.3% | |
| – | +1.1% | -0.6% | +1.4% | +0.8% | +1.1% | +1.5% | +1.1% | +0.2% | +0.3% | -0.1% | -0.9% | |
| – | -43.9% | -3.7% | +264.7% | -180.4% | +225.3% | -13.8% | +272.8% | -87.8% | +309.2% | +244.5% | -84.9% | |
| – | -72.8% | +1,262.2% | -101.8% | – | -189.2% | -89.6% | +451.6% | – | -133.0% | – | -640.7% | |
| – | -173.8% | – | -152.4% | – | -236.8% | -66.0% | +288.2% | – | -641.2% | +107.4% | -33.4% | |
| – | – | +182.1% | +11.0% | -169.5% | – | +14.7% | -150.6% | – | -459.6% | – | +886.3% | |
| – | +6.3% | +1.0% | +16.5% | +4.5% | -1.8% | +100.6% | -8.9% | -22.9% | +9.2% | +8.7% | +2.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.